Note: Ingredients listed on restricted chemical lists
EC/CAS
201-770-2/87-78-5
Name of the chemical
mannitol
Concentration
Proprietary
EC/CAS
231-791-2/7732-18-5
Name of the chemical
Water, distilled, conductivity or of similar purity H2O
Concentration
Proprietary
General Information
Revision date
2015-08-03
Product name
CARBOPLATIN INJECTION
Chemical name
Platinum diammine [1 1-cyclobutanedicarboxylato (2-)-0 0"]- (SP-4-2)
Emergency telephone
1-800/424-9300
Icons in SDS
Company Information
company name
TEVA
e-mail address of the competent person responsible for the Safety Data Sheet
TevaSDSRequest@tevapharm.com
Section 2
SECTION 2: Hazards identification
Principle Routes of Exposure
MUST BE AVOIDED. Product Description This product is clear, odorless liquid. Health In the workplace, exposure via inhalation and skin contact may cause irritation. Accidental injection or ingestion may be toxic. In therapeutic use, adverse effects reported include sensitization and allergic reaction that may be severe (anaphylactic and anaphylactoid reactions) in susceptible individuals. This material has caused bone marrow suppression, leading to bleeding and infection. This material has been shown to be a reproductive toxin in animal tests, causing mutagenic and teratogenic effects. These effects may be possible as a result of workplace exposure. Refer to
TOXICOLOGICAL INFORMATION
for additional information on adverse effects. Flammability Hazards This product not flammable or combustible. When involved in a fire, this product may ignite and produce irritating vapors and toxic compounds (including carbon and nitrogen oxides). Reactivity Hazards: This product is not reactive.
Environmental hazards
This product has not been tested for environmental harm; all release to the environment should be avoided. Emergency Recommendations: Emergency responders must wear personal protective equipment suitable for the situation to which they are responding.
